1-4 of 4
Dirk Kienle, MD
Close
Sort by
Journal Articles

Telomere Length in Mantle Cell Lymphoma.

Billy Michael Chelliah Jebaraj, M.Sc., Dirk Kienle, MD, German Ott, MD, Andreas Rosenwald, MD, Thomas F.E. Barth, Peter Möller, MD, Thorsten Zenz, MD, Hartmut Döhner, MD, Stephan Stilgenbauer, MD
Journal: Blood
Blood (2012) 120 (21): 2509.
https://doi.org/10.1182/blood.V120.21.2509.2509
Published: 2012
Journal Articles

Array-CGH Based Genomic Profiling in B-Cell Chronic Lymphocytic Leukemia Reveals Specific Correlations of Genomic Imbalances and Prognostic Subgroups and Underlines the Consistency of Chromosomal Aberration Patterns within This Disease.

Carsten Schwaenen, MD, Dirk Kienle, MD, Alexander Krober, MD, Sandra Ruf, Dirk Winkler, MD, Holger Kohlhammer, MD, Hans A. Kestler, PhD, Peter Lichter, PhD, Swen Wessendorf, MD, Hartmut Dohner, MD, Stephan Stilgenbauer, MD
Journal: Blood
Blood (2006) 108 (11): 2083.
https://doi.org/10.1182/blood.V108.11.2083.2083
Published: 2006
Journal Articles

17p Deletion Predicts for Inferior Overall Survival after Fludarabine - Based First Line Therapy in Chronic Lymphocytic Leukemia: First Analysis of Genetics in the CLL4 Trial of the GCLLSG.

Stephan Stilgenbauer, MD, Alexander Kröber, MD, Raymonde Busch, PhD, Barabara Eichhorst, MD, Dirk Kienle, MD, Dirk Winkler, MD, Georg Hopfinger, MD, Peter Lichter, MD, Bertold Emmerich, MD, Michael Hallek, MD, Hartmut Döhner, MD, The GCLLSG
Journal: Blood
Blood (2005) 106 (11): 715.
https://doi.org/10.1182/blood.V106.11.715.715
Published: 2005
Journal Articles

Subcutaneous Campath-1H (Alemtuzumab) in Fludarabine-Refractory Cll: Interim Analysis of the CLL2h Study of the German Cll Study Group (GCLLSG).

Stephan Stilgenbauer, MD, Dirk Winkler, MD, Alexander Kröber, MD, Dirk Kienle, MD, Michael Hallek, MD, Manfred Hensel, MD, Eva Lengfelder, MD, Lorenz Trümper, MD, Peter Dreger, MD, Ulrich Jäger, MD, Hartmut Döhner, MD, the GCLLSG
Journal: Blood
Blood (2004) 104 (11): 478.
https://doi.org/10.1182/blood.V104.11.478.478
Published: 2004